ChemoCentryx
CCXI
#3552
Rank
A$5.63 B
Marketcap
A$78.31
Share price
0.00%
Change (1 day)
29.67%
Change (1 year)

Market capitalization of ChemoCentryx (CCXI)

Last known market cap: A$5.63 Billion

On November 25, 2022 ChemoCentryx had a market cap of A$5.63 Billion. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of ChemoCentryx from 2012 to 2022

End of year Market Cap

Year Marketcap Change
2022A$5.49 B56.22%
2021A$3.51 B-36.89%
2020A$5.57 B63.79%
2019A$3.40 B333.76%
2018A$0.78 B111.06%
2017A$0.37 B-24.27%
2016A$0.49 B-0.11%
2015A$0.49 B35.5%
2014A$0.36 B30.24%
2013A$0.27 B-27.26%
2012A$0.38 B

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Biogen
BIIB
A$38.85 B 589.90%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
A$593.64 B 10,440.20%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
A$144.23 B 2,460.88%๐Ÿ‡ฌ๐Ÿ‡ง UK
Bristol-Myers Squibb
BMY
A$155.31 B 2,657.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
A$725.67 B 12,784.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
A$254.56 B 4,419.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
A$216.93 B 3,751.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
A$49.35 B 776.32%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Merck
MRK
A$364.53 B 6,372.41%๐Ÿ‡บ๐Ÿ‡ธ USA